The aim of the present study was to identify the genes differentially expressed in the visceral adipose tissue in a well-characterised mouse model of high-fat diet (HFD)-induced obesity. Male C57BL/6J mice (n 20) were fed either HFD (189 % of energy from fat) or low-fat diet (LFD, 42 % of energy from fat) for 16 weeks. HFD-fed mice exhibited obesity, insulin resistance, dyslipidaemia and adipose collagen accumulation, along with higher levels of plasma leptin, resistin and plasminogen activator inhibitor type 1, although there were no significant differences in plasma cytokine levels. Energy intake was similar in the two diet groups owing to lower food intake in the HFD group; however, energy expenditure was also lower in the HFD group than in the LFD group. Microarray analysis revealed that genes related to lipolysis, fatty acid metabolism, mitochondrial energy transduction, oxidation -reduction, insulin sensitivity and skeletal system development were down-regulated in HFD-fed mice, and genes associated with extracellular matrix (ECM) components, ECM remodelling and inflammation were up-regulated. The top ten up-or down-regulated genes include Acsm3, mt-Nd6, Fam13a, Cyp2e1, Rgs1 and Gpnmb, whose roles in the deterioration of obesity-associated adipose tissue are poorly understood. In conclusion, the genes identified here provide new therapeutic opportunities for prevention and treatment of diet-induced obesity.
Obesity is one of the major underlying causes of the metabolic syndrome, including insulin resistance, type 2 diabetes and dyslipidaemia. Although the exact mechanisms by which obesity induces or worsens the metabolic risk factors are still unknown, excess adiposity, particularly visceral fat accumulation, is associated with insulin resistance and abnormal glucose and lipid metabolisms (1) . In addition, chronic lowgrade inflammation in the adipose tissue contributes to the pathogenesis of insulin resistance and metabolic syndrome (1) . Diet composition plays an important role in the development of obesity and its associated metabolic diseases (2) .
Dietary fat is the most energy-dense macronutrient and causes less satiety than carbohydrate or protein (2) . Prolonged ingestion of high-fat diet (HFD) has been found to induce hyperphagia, body-weight gain and fat deposition and increase the levels of circulating glucose, insulin and TAG in rats (3 -5) . However, results have been inconsistent, with some studies reporting that HFD did not cause hyperphagia, hypertriglycerolaemia, hyperglycaemia or hyperinsulinaemia in mice (6, 7) .
Carbohydrates, especially simple sugars, also seem to be associated with obesity and metabolic syndrome. Longterm ingestion of a sugar-rich diet increases fat mass without † These authors contributed equally to this work. a concomitant increase in energy intake (8) and promotes insulin resistance in rats (9) . Furthermore, a low-fat, highcarbohydrate diet had deleterious effects on cardiovascular health in obese adults compared with a high-fat, lowcarbohydrate diet (10) . In contrast, another study has shown that a high-fat, low-carbohydrate diet decreases serum TAG levels and increases serum HDL-cholesterol levels in obese subjects, without concomitant changes in body weight or composition, in comparison with a low-fat, highcarbohydrate diet (11) . These results show that the role of diet in obesity varies with diet composition, animal species and experimental protocol.
Recently, nutritional genomics studies have analysed the responses of tissues to different diets and nutrients in order to provide a insight into the molecular events underlying diet-induced obesity (12) . However, obesity-related metabolic and molecular changes in response to HFD (containing low carbohydrate) v. low-fat diet (LFD; containing high carbohydrate)
are not yet fully understood. Moreover, the HFD used in most animal studies of diet-induced obesity contains an extremely high fat content (approximately 60 % of total energy) (11) , which does not mimic the moderate fat content of Western human diets (approximately 40 -45 % of total energy).
Therefore, the primary aim of the present study was to compare the effects of long-term ingestion of HFD (189 % of energy from fat) and LFD (which provides more carbohydrate, namely maize starch and sugar) on food intake, energy expenditure, body weight and adiposity, as well as plasma glucose, insulin, lipid and adipocytokine profiles, in C57BL/6J mice. The secondary aim of the present study was to obtain a further insight into the molecular mechanisms underlying the development of diet-induced obesity and its related metabolic abnormalities in response to HFD and to identify differentially expressed genes in the epididymal white adipose tissue (WAT) of HFD-fed mice using microarray analysis.
Experimental methods

Feeding protocol, energy expenditure and blood biomarkers
Male C57BL/6J mice (4-week old) were purchased from Jackson Laboratories and individually housed at room temperature on a 12 h light -12 h dark cycle. After 1 week of acclimation, they were fed a LFD (D12450B, 16·17 kJ/g; Research Diets) or a HFD (D12451, 19·866 kJ/g; Research Diets) ad libitum for 16 weeks. The LFD contains 42 % of energy from fat (25·2 % of energy from soyabean oil and 16·8 % of energy from lard), 294 % of energy from carbohydrate (130·2 % of energy from maize starch, 16·8 % of energy from maltodextrin and 147 % of energy from sucrose) and 84 % of energy from protein, whereas the HFD contains 189 % of energy from fat (25·2 % of energy from soyabean oil and 163·8 % of energy from lard), 147 % of energy from carbohydrate (29·4 % of energy from maize starch, 42 % of energy from maltodextrin and 75·6 % of energy from sucrose) and 84 % of energy from protein. Food intake of each mouse was measured daily throughout the study by subtracting the remaining food from the amount of food given to the mice, and daily food intake was calculated from the averaged food intake throughout the study. Energy expenditure for 24 h was measured at 14 weeks of feeding on the experimental diets using an indirect calorimeter (Oxylet; Panlab). Mice were killed as described previously (6) , and epididymal WAT, perirenal WAT, retroperitoneal WAT, mesenteric WAT and subcutaneous WAT were promptly removed, rinsed with physiological saline and weighed after blood collection. Among them, the epididymal WAT, which is widely used for the metabolic study due to its anatomically distinct feature, relative abundance and metabolic sensitivity (13 -18) , was immediately fixed in 10 % buffered formalin for morphological examination and was frozen in liquid N 2 and stored at 2708C until RNA analysis. Plasma concentrations of NEFA, phospholipid (Wako Chemicals), TAG, total cholesterol and HDL-cholesterol (Asan Pharmaceutical Co., Ltd) were determined using commercially available kits.
Plasma adipocytokine and insulin levels were determined using a multiplex detection kit (Bio-Rad) and analysed using a Luminex 200 Labmap system. Fasting blood glucose concentration was measured using a glucose analyser (Glucocard; Arkray), and the homeostatic index of insulin resistance (HOMA-IR) was calculated as (fasting glucose (mmol/l) £ fasting insulin (pmol/l)/135). All the experimental procedures were approved by the Kyungpook National University Ethics Committee (Approval no. KNU-2011-49).
Morphology of the epididymal white adipose tissue
The epididymal WAT was fixed in 10 % buffered formalin. Fixed tissues were embedded in paraffin, and 4 mm sections were prepared and stained with haematoxylin and eosin and Masson's trichrome. The stained areas were viewed using an optical microscope (Nikon) with a magnification of 200 £ , and epididymal adipocyte size and fibrotic area from the Masson's trichrome staining were measured by computer analysis using the Leica Application Suite (version 2·8·1; Leica Microsystems).
RNA isolation, microarray analysis and real-time quantitative PCR
Total RNA was extracted from the epididymal WAT using TRIzol reagent (Invitrogen Life Technologies). For quality control, RNA purity and integrity were assessed using an Agilent 2100 Bioanalyzer (Agilent Technologies). Three pooled RNA sample sets were constructed to represent the LFD and HFD groups, as described previously (19) . For microarray analysis, total RNA was amplified and purified using an Illumina RNA amplification kit (Ambion w ) and quantified using an ND-1000 spectrophotometer (NanoDrop). Biotinylated cRNA (750 ng) was hybridised to MouseWG-6 v2·0 Expression BeadChips (Illumina, Inc.) at 588C for 16 -18 h. Array signal detection was carried out using Amersham Cy3-streptavidin (GE Healthcare Bio-Sciences). BeadChips were scanned using an Illumina BeadArray Reader, and raw data were extracted using the Illumina BeadStudio software. Probe signal intensities were quantile-normalised and log-transformed. Limma was used to determine significantly differentially expressed genes based on a false discovery rate less than 5 %, a Benjamin and Hochberg-adjusted P value , 0·05 and a log 2 fold change greater than 1 (19) . The DAVID Functional Annotation Tool was used to identify the enriched biological themes and cluster-redundant annotation terms. These microarray data were deposited in Gene Expression Omnibus database (accession no. GSE63198).
To validate microarray data, several differentially expressed genes (Rgs1, Mmp2, Ccl2, Tlr2, Tlr4 and Irs2) were measured independently by real-time quantitative PCR using the same pooled RNA samples that were hybridised to BeadChips. Total RNA (1 mg) was reverse-transcribed into complementary DNA using a QuantiTect reverse transcription kit (Qiagen), and real-time quantitative PCR was carried out on a CFX96 real-time system (Bio-Rad) using a SYBR Green PCR kit (Qiagen). Values were normalised to glyceraldehyde-3-phosphate dehydrogenase levels, and relative gene expression was calculated by the 2 2DDCt method. For definition of gene abbreviations, see online Supplementary Table S1 .
Statistical analyses
All data are presented as means with their standard errors. Statistical analyses were performed using SPSS software. Changes in body weight were analysed by repeated-measures ANOVA, and other data were analysed by Student's t test or Wilcoxon t test. Results were considered statistically significant when P, 0·05.
Results
High-fat diet decreased food intake but increased body weight and fat mass by decreasing energy expenditure HFD-fed mice exhibited a significantly greater body weight than LFD-fed mice, although the average daily food intake throughout the study was markedly lower in HFD-fed mice and the average daily energy intake did not differ between the two groups ( Fig. 1(a) -(c) ). Interestingly, indirect calorimetry revealed that HFD-fed mice had lower energy expenditure than LFD-fed mice ( Fig. 1(d) ). As expected, the subcutaneous WAT and the visceral WAT (including epididymal, perirenal, retroperitoneal and mesenteric WAT) weights, adipocyte size and adipose collagen accumulation were higher in HFD-fed mice ( Fig. 1 (e) and (f)). 
High-fat diet induced hyperglycaemia, hyperinsulinaemia and insulin resistance
Fasting blood glucose level was significantly increased in HFD-fed mice ( Fig. 1(g) ). HFD also resulted in significant increases in plasma insulin level and HOMA-IR compared with LFD ( Fig. 1 
(h) and (i)).
High-fat diet increased plasma leptin, resistin and plasminogen activator inhibitor type 1 levels but did not alter plasma adiponectin and cytokine levels Plasma leptin, resistin and plasminogen activator inhibitor type 1 levels were significantly higher in HFD-fed mice than in LFD-fed mice (Table 1) . However, there was no significant difference in plasma adiponectin level between the two groups. The levels of plasma cytokines (monocyte chemotactic protein 1, TNF-a, IL-6 and IL-10) were also not significantly altered by HFD.
High-fat diet increased plasma phospholipid, total cholesterol and HDL-cholesterol levels but did not alter plasma NEFA and TAG levels No significant differences in plasma NEFA or TAG levels were observed between the HFD and LFD groups (Table 1) . However, plasma phospholipid level was significantly higher in HFD-fed mice. HFD also increased plasma total cholesterol level, as well as HDL-cholesterol level, resulting in no significant difference in atherogenic index between the two groups.
Gene expression profiles in the epididymal white adipose tissue
To determine the changes in global gene expression profiles of the epididymal WAT in HFD-induced obesity, we identified differentially expressed genes in HFD-fed mice compared with LFD-fed mice using microarray analysis. Of the 45 000 analysed expression probes, 1270 were different between the two groups. Among these 1270 HFD-responsive genes, 657 were up-regulated and 397 were down-regulated. The top ten differentially expressed genes are listed in Table 2 . Functional annotation clustering using DAVID revealed that the majority of genes up-regulated by HFD were related to immune and inflammatory responses (Table 3; online  Supplementary Table S2 ). These included genes encoding chemokines, receptors of chemokines and cytokines, tolllike receptors, C-type lectin receptors, Fc receptors and surface markers of immune cells (Table 4) . Moreover, HFD induced up-regulation of genes encoding extracellular matrix (ECM) components such as collagen (Col1a1, Col3a1, Col5a2, Col6a2 and Col6a3), glycosaminoglycan and proteoglycan (Sdcbp and Lum), adhesive glycoproteins (Mfap5, Gpnmb and Fn1) and integrin (Itgad, Itgam and Itgax), as well as genes encoding proteins involved in ECM remodelling and regulation, such as cathepsins (Ctsa, Ctsh, Ctsk, Ctsl, Ctss and Ctsz), a disintegrin and metalloprotease (ADAM) domain (Adam8, Adam12 and Adam17), matrix metalloproteinases (MMP: Mmp2, Mmp3, Mmp12 and Mmp13), tissue inhibitors of metalloproteinases (Timp1) and other fibrosis-related genes (Tgfb1). Interestingly, the expression of two ADAM and MMP genes, Adam7 and Mmp9, was down-regulated in obesity.
The genes that were down-regulated in response to HFD were enriched in gene ontology categories related to oxidation -reduction, fatty acid metabolism, insulin response and skeletal system development (Table 3; online Supplementary Table S2 ). Down-regulated genes related to oxidation -reduction included genes controlling antioxidant defence (Gpx3), detoxification (Aldh1a1, Aldh6a1, Cyp2d9, Cyp2d22, Cyp2e1, Cyp2f2, Gsta3 and Gsta4) and mitochondrial energy transduction pathways such as the TCA cycle (Por) and oxidative phosphorylation (Ndufb4 and Ndufb9) ( Table 4) . HFD decreased the expression of genes involved in lipolysis, thermogenesis (Adrb3) and fatty acid uptake, transport (Fabp4, Cd36 and Slc27a2), elongation (Elovl6), activation and oxidation (Acsm3, Acacb, Acot4, Acadsb, Hadh and Faah). Consistent with increased insulin resistance, Table 2 . Top ten differentially expressed genes in the epididymal white adipose tissue of high-fat diet-fed mice Differentially expressed genes* Up-regulated genes Rgs1, Mmp12, Gpnmb, Trem2, Tph2, Saa3, Ubd, Atf3, Itgad, Cd68 Down-regulated genes Acsm3, Pck1, Fabp4, LOC384538, mt-Nd6, Ffar3, 1810022C23Rik, Fam13a, Cyp2e1, scl33870·2_144
* Differentially expressed genes were determined using Limma in R/Bioconductor, based on P,0·05, false discovery rate ,5 % and log 2 fold change . 1. For definition of gene abbreviations, see online Supplementary Table S1 . insulin sensitivity-related genes, such as those encoding insulin receptor substrate 2 (Irs2) and GLUT 3 (Slc2a3), were down-regulated by HFD feeding. Along with Mmp9, multiple genes controlling skeletal system development and pattern specification (Bmp4, Hoxa5, Hoxa7, Hoxb5, Hoxc6, Irx3 and Igf2) were also down-regulated in HFD-fed mice. The expression of many genes encoding G-protein-coupled receptors (GPCR: Gpr64, Gpr120, Gpr109a, Gpr156 and Opn3) was decreased in response to HFD, whereas mRNA expression of regulators of G protein signalling (RGS: Rgs1 and Rgs10) was increased. Several genes identified as differentially expressed based on microarray analysis were independently validated by real-time quantitative PCR (Fig. 2) .
Discussion
It is generally accepted that HFD induces hyperphagia, and that increased energy intake is the major mechanism by which HFD causes obesity (2, 3) . In the present study, however, despite lower food intake and similar energy intake, mice fed HFD (189 % of energy from fat) for 16 weeks gained more body weight and body fat than mice fed LFD (42 % of energy from fat), which provided more energy as carbohydrate (sugar and maize starch). This is consistent with a previous finding that body weight and adiposity, but not energy intake, increased in HFD-fed C57BL/6J mice compared with LFD-fed mice during the first 17 weeks of feeding, although energy intake was significantly higher in HFDfed mice after 17 weeks owing to a reduction in leptin sensitivity (20) . Body weight is normally maintained by a balance between energy intake and energy expenditure. When energy intake exceeds energy expenditure, excess energy is stored as TAG in the adipose tissue, resulting in overweight or obesity. Because energy expenditure during dark hours was significantly lower in HFD-fed mice than in LFD-fed mice, the increase in body weight and fat mass in HFD-fed mice may be due to a positive energy balance resulting from a decrease in energy expenditure relative to energy intake. Induction of energy expenditure based on fatty acid oxidation in WAT may reduce adiposity (21) . Mitochondrial biogenesis and thermogenesis are decreased in WAT of obese individuals and rodents (21 -23) , while induction of mitochondria and activation of fatty acid oxidation have been observed in WAT under conditions promoting loss of adiposity (21) .
Kusminski and Scherer (24) suggested that in the obese state, mitochondria in WAT cannot cope with increasing demands for fatty acid oxidation, resulting in incomplete b-oxidation. In the present study, HFD down-regulated the expression of genes involved in fatty acid catabolism and oxidation, as well as genes controlling the mitochondrial energy transduction pathways, including the TCA cycle and oxidative phosphorylation, in the epididymal WAT. In other studies, expression of Faah (a catabolic gene for bioactive fatty acid amides) in adipose tissue was negatively correlated with visceral fat mass in human subjects (25) , and mice lacking Faah had increased body weight and fat mass with decreased energy expenditure (26) . Thus, down-regulation of genes regulating fatty acid catabolism, fatty acid oxidation and energy metabolism in epididymal WAT may be partly responsible for the decrease in energy expenditure induced by HFD. Our findings also suggest that the deleterious effects of HFD on adipose tissue mitochondria are associated with decreased expression of genes involved in antioxidant defence and detoxification. An altered redox state is associated with the accumulation of products of incomplete b-oxidation and increased mitochondrial reactive oxygen species formation, leading to a deterioration of insulin sensitivity (27) . Mitochondrial reactive oxygen species produced by redox imbalance may promote adipocyte differentiation (28) . In adipose tissue of obese mice such as KKAy mice and HFD-induced obese mice, reactive oxygen species production was accompanied by decreased expression of antioxidant enzymes (29) . In the present study, another candidate gene for controlling energy expenditure is the bone morphogenetic protein 4 (Bmp4) gene. Recently, Qian et al. (30) reported that adiposespecific overexpression of Bmp4 led to reduced body fat mass and increased energy expenditure, whereas Bmp4-deficient mice exhibited increased adiposity and impaired insulin sensitivity, which suggests that Bmp4 can regulate WAT remodelling and induction of brown adipocyte-like cell structure and function. Interestingly, along with Bmp4, multiple genes involved in skeletal system development and pattern specification were down-regulated in the present study. Similarly, down-regulation of homeobox genes, including Hoxa5, was observed in the epididymal WAT of ob/ob mice compared with lean controls (31) , whereas expression of homeobox genes (e.g. Hoxa5, Hoxb5, Hoxc6 and Irx3) was up-regulated after fat loss in human subjects (32) . Recently, Gehrke et al. (33 ) suggested epigenetic regulation, in particular DNA methylation of HOX genes as a mechanism that explains Table S1 .
how these transcriptional factors exhibit such a distinct depotspecific expression pattern. Different adipose depots are known to mediate different effects on the risk for metabolic disorders (33) . Moreover, obese patients with type 2 diabetes had lower expression of Igf2 in the adipose tissue compared with those who were lean (34) , and down-regulation of Igf2 in the adipose tissue contributed to the paternal transmission of HFD-induced obesity (35) . However, many genes related to skeletal system development and pattern specification still have unknown roles in the development of obesity. Thus, understanding these genes will facilitate the development of novel approaches in the treatment of obesity.
In contrast, since the NEFA released by lipolysis or taken up by cells can be utilised in WAT as a source of energy through b-oxidation in the mitochondria, a decrease in the expression of genes involved in lipolysis and fatty acid uptake and transport in response to HFD may reduce b-oxidation, resulting in excessive fat accumulation. In mice, Adrb3 disruption reduces lipolysis and increases body fat accumulation (36) , and Adrb3 increases thermogenesis in the brown adipose tissue (37) . Deficiency of Fabp4 also reduces lipolysis in mice (38) , and a decrease in Fabp4 expression in the adipose tissue has been found to be inversely associated with obesity in human subjects (39) . The expression of several GPCR genes, including Gpr64, Gpr120, Gpr109a, Gpr156 and Opn3, was down-regulated by HFD in the present study. Mice lacking Gpr120, an NEFA-sensing GPCR, exhibited obesity, glucose intolerance and fatty liver (40) . Furthermore, Gpr109a has been reported to act as a metabolic sensor activated by intermediates of energy metabolism, and its expression was down-regulated in the adipose tissue of HFD-fed mice (41) . In contrast, the expression of genes encoding RGS (Rgs1 and Rgs10) was up-regulated by HFD. The RGS family is involved in the rapid turn-off of GPCR signalling pathways (42) . Huang et al. (43) demonstrated that RGS-insensitive Gai2G184S mice exhibited resistance to the metabolic effects of HFD, and were protected from insulin resistance by increasing energy expenditure and peripheral insulin sensitivity. Furthermore, in another study, Rgs2-and Rgs5-deficient mice had less body mass and body fat than littermate controls (44, 45) . However, the specific roles of most GPCR and RGS genes in the adipose tissue are not yet fully understood.
Obesity is characterised by extensive reorganisation of the adipose tissue, which involves ECM remodelling and adipogenesis (46) . Cathepsins, ADAM, MMP and their inhibitors (i.e. TIMP) are involved in ECM remodelling (47) . The present study indicated that mRNA levels of most genes involved in ECM remodelling were up-regulated in obese adipose tissues compared with lean tissues, while expression of Adam7 and Mmp9 was down-regulated in obesity. Interestingly, mice lacking Ctsk, Ctsl, Adam12, Timp1 or Mmp2, but not Mmp9, were protected against obesity (48 -53) . Belo et al. (54) reported the association between Mmp9 gene polymorphisms and lower plasma Mmp9 level in obese children and adolescents, suggesting a potential role of Mmp9 gene in the development of obesity. We also observed that HFD up-regulated the expression of Tgfb1 (encoding a profibrotic cytokine), as well as genes encoding various ECM components, including members of the collagen family, and increased adipose collagen accumulation, suggesting that HFD may facilitate abnormal ECM accumulation in WAT, promoting fibrosis. In addition, we detected significant expression of genes for a lymphocyte chemotactic factor (Cxcl12) and its receptor (Cxcr4), as well as genes related to macrophage infiltration (Ccl2, Cxcl14 and Ccr5) in WAT of HFD-fed mice. It is well known that macrophage infiltration plays a critical role in adipose tissue inflammation, and that chemokines are involved in this process. In obese mice, a deficiency of Ccl2, Cxcl14 or Ccr5 decreased macrophage infiltration in the adipose tissue and improved metabolic function, while overexpression of Ccl2 in the adipose tissue caused the opposite phenotype (55 -58) . Besides macrophages, T and B lymphocytes have been shown to accumulate in the adipose tissue of obese mice and have been associated with inflammation and insulin resistance (59, 60) . Many other genes involved in innate or adaptive immune and inflammatory responses, such as those encoding toll-like receptors, C-type lectin receptors, Fc receptors, cytokine receptors and triggering receptors, were up-regulated by HFD. One of these genes, Tlr2, has been associated with increased adiposity, macrophage infiltration and inflammatory cytokine expression (61) . Saa3, which encodes an inflammatory adipocytokine and may be a potential link between obesity and its metabolic complications (62) , was also one of the top ten genes up-regulated by HFD in the present study. However, despite the increased expression of multiple inflammatory genes in WAT of HFD-fed mice, plasma concentrations of inflammatory chemokines and cytokines were not affected, as described in a previous study (63) . Thomas et al. (63) suggested that shifts in these inflammation markers in the blood are probably not as sensitive as WAT mRNA patterns, which reflect the inflammatory status of the local tissue. Tph2, Ubd and Atf3 were also among the genes most highly up-regulated by HFD in the present study. Although a deficiency of Tph2 or Ubd in mice caused body fat reduction by increasing energy expenditure (64, 65) , the specific functions of these genes in the adipose tissue are still unclear. Atf3 has been reported to act as a negative regulator of SFA/TLR4 signalling and macrophage activation in obese adipose tissue (66) ; however, overexpression of Atf3 decreased mitochondrial function and mitochondria-related gene expression in adipocytes in vivo and in vitro (67) . Thus, further experiments are required to evaluate whether Atf3 has a beneficial or detrimental role in obesity and its associated metabolic disturbances.
In conclusion, long-term HFD feeding predominantly up-regulated a series of genes involved in immune and inflammatory responses, as well as cell activation and division in WAT of C57BL/6J mice. Genes down-regulated by HFD were mainly implicated in fatty acid metabolism, oxidationreduction, insulin response and skeletal system development. The top ten up-regulated genes were Rgs1, Mmp12, Gpnmb, Trem2, Tph2, Saa3, Ubd, Atf3, Itgad and Cd68, which might be associated with energy expenditure (Rgs1, Tph2, Ubd and Atf3), ECM remodelling and components (Mmp12, Gpnmb and Itgad) and inflammation (Trem2, Saa3, Atf3 and Cd68); further studies are needed to evaluate the roles of these genes in the pathophysiology of the adipose tissue. The functions of the top ten down-regulated genes, except Pck and Fabp4, are also poorly understood. Thus, the present findings will be useful in future efforts to identify the therapeutic targets for obesity. However, further studies are needed to investigate the molecular mechanisms responsible for WAT depot-specific differences.
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